GELSEAL TM TRIAXIAL VASCULAR GRAFT

Graft, Vascular, Synthetic/biologic Composite

FDA Premarket Approval P890045

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

DeviceGELSEAL TM TRIAXIAL VASCULAR GRAFT
Classification NameGraft, Vascular, Synthetic/biologic Composite
Generic NameGraft, Vascular, Synthetic/biologic Composite
ApplicantCARBOMEDICS, INC.
Date Received1989-08-21
Decision Date1993-01-11
Notice Date1993-05-03
PMAP890045
SupplementS
Product CodeMAL
Docket Number93M-0023
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address CARBOMEDICS, INC. 1300-d East Anderson Ln. austin, TX 78752

Supplemental Filings

Supplement NumberDateSupplement Type
P890045Original Filing
S006 1994-04-18 Normal 180 Day Track
S005 1994-03-31 Normal 180 Day Track
S004
S003 1993-11-05 Normal 180 Day Track
S002
S001 1993-07-08 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
05037881110585 P890045 000
05037881101194 P890045 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.